Cornerstone partners with biotech and pharmaceutical companies at every stage of clinical development, from IND-enabling studies through Phase IV post-market surveillance and regulatory submission.
Partner With UsEnd-to-end trial operations including site selection, patient recruitment, monitoring, and data management across 40+ countries.
FDA, EMA, and PMDA submission strategy, IND/NDA/BLA preparation, and global regulatory intelligence consulting.
Signal detection, periodic safety reports, risk management plans, and post-market surveillance for marketed therapeutics.